Myeloid Malignancy Interest Group
The Myeloid Malignancy Interest Group is a trans-NIH multidisciplinary network of researchers and clinicians dedicated to improving early detection, diagnosis, prognosis and development of novel therapeutics for myeloid malignancies. For more information, see https://ccr.cancer.gov/myeloid-malignancies-program.
Representatives of this interest group include:
- Peter D. Aplan, M.D.
- Christopher S. Hourigan, M.D., D.Phil.
- Paul Liu, Ph.D.
- Steven Z. Pavletic, M.D.
- Nirali N. Shah, M.D.
To join the Myeloid Malignancy Interest Group mailing list, please visit the Myeloid Malignancy Interest Group Listserv home page, then click the “Subscribe or Unsubscribe” link in the right sidebar.
- Nirali Shah, M.D., NCI-CCR
- Christopher Hourigan, M.D., D.Phil., NHLBI
- Steven Pavletic, M.D., NCI-CCR
- Peter Aplan, M.D, NCI-CCR
- Paul Liu, Ph.D., NHGRI
Myeloid Malignancy Interest Group site
Scientific Focus Areas
View SIGs in Clinical Research
This page was last updated on Wednesday, May 18, 2022